Although the dhr could not be reviewed because the lot number remains unknown, there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device was not available; therefore, a visual inspection as well as a functional evaluation could not be performed.The reported event was unable to be confirmed and it cannot be confirmed if the stent met specification, as the stent was not returned.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.It was reported that intraoperative rupture occurred during coil embolization of an unruptured aneurysm using the subject stent atlas and target coils.The patient's outcome was unknown.The risk of the reported aneurysm rupture and intracranial hemorrhage are documented in the atlas dfu, as potential adverse events which can occur as a result of these type of procedures, there was no indication of device malfunction or failure, therefore an assignable cause of anticipated procedural complication, will be assigned to the reported 'patient aneurysm rupture and 'patient intracranial hemorrhage'.This is 2 of 2 reports.
|